WO2002020754A3 - Molecules utilisees a des fins diagnostiques et therapeutiques - Google Patents
Molecules utilisees a des fins diagnostiques et therapeutiques Download PDFInfo
- Publication number
- WO2002020754A3 WO2002020754A3 PCT/US2001/027127 US0127127W WO0220754A3 WO 2002020754 A3 WO2002020754 A3 WO 2002020754A3 US 0127127 W US0127127 W US 0127127W WO 0220754 A3 WO0220754 A3 WO 0220754A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dithp
- provides
- therapeutics
- diagnostics
- diagnostic assays
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01966454A EP1364015A2 (fr) | 2000-09-05 | 2001-08-29 | Molecules pour diagnostic et traitement |
CA002421265A CA2421265A1 (fr) | 2000-09-05 | 2001-08-29 | Molecules utilisees a des fins diagnostiques et therapeutiques |
AU8696401A AU8696401A (en) | 2000-09-05 | 2001-09-02 | Molecules for diagnostics and therapeutics |
Applications Claiming Priority (44)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23058300P | 2000-09-05 | 2000-09-05 | |
US22974700P | 2000-09-05 | 2000-09-05 | |
US22974900P | 2000-09-05 | 2000-09-05 | |
US22975000P | 2000-09-05 | 2000-09-05 | |
US22974800P | 2000-09-05 | 2000-09-05 | |
US22975100P | 2000-09-05 | 2000-09-05 | |
US60/229,751 | 2000-09-05 | ||
US60/230,583 | 2000-09-05 | ||
US60/229,750 | 2000-09-05 | ||
US60/229,749 | 2000-09-05 | ||
US60/229,747 | 2000-09-05 | ||
US60/229,748 | 2000-09-05 | ||
US23059800P | 2000-09-06 | 2000-09-06 | |
US23051400P | 2000-09-06 | 2000-09-06 | |
US23098800P | 2000-09-06 | 2000-09-06 | |
US23059900P | 2000-09-06 | 2000-09-06 | |
US23051700P | 2000-09-06 | 2000-09-06 | |
US23059500P | 2000-09-06 | 2000-09-06 | |
US23051500P | 2000-09-06 | 2000-09-06 | |
US23086500P | 2000-09-06 | 2000-09-06 | |
US23051800P | 2000-09-06 | 2000-09-06 | |
US23059700P | 2000-09-06 | 2000-09-06 | |
US23051900P | 2000-09-06 | 2000-09-06 | |
US23061000P | 2000-09-06 | 2000-09-06 | |
US23050500P | 2000-09-06 | 2000-09-06 | |
US60/230,505 | 2000-09-06 | ||
US60/230,865 | 2000-09-06 | ||
US60/230,988 | 2000-09-06 | ||
US60/230,518 | 2000-09-06 | ||
US60/230,597 | 2000-09-06 | ||
US60/230,599 | 2000-09-06 | ||
US60/230,515 | 2000-09-06 | ||
US60/230,519 | 2000-09-06 | ||
US60/230,598 | 2000-09-06 | ||
US60/230,514 | 2000-09-06 | ||
US60/230,595 | 2000-09-06 | ||
US60/230,610 | 2000-09-06 | ||
US60/230,517 | 2000-09-06 | ||
US23095100P | 2000-09-07 | 2000-09-07 | |
US23116700P | 2000-09-07 | 2000-09-07 | |
US23116300P | 2000-09-07 | 2000-09-07 | |
US60/231,163 | 2000-09-07 | ||
US60/230,951 | 2000-09-07 | ||
US60/231,167 | 2000-09-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002020754A2 WO2002020754A2 (fr) | 2002-03-14 |
WO2002020754A3 true WO2002020754A3 (fr) | 2003-09-25 |
Family
ID=27586647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/027127 WO2002020754A2 (fr) | 2000-09-05 | 2001-08-29 | Molecules utilisees a des fins diagnostiques et therapeutiques |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1364015A2 (fr) |
CA (1) | CA2421265A1 (fr) |
WO (1) | WO2002020754A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020102637A1 (en) * | 2000-12-21 | 2002-08-01 | Chunhua Yan | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
AU2002250143A1 (en) * | 2001-03-16 | 2002-10-03 | Eli Lilly And Company | Lp mammalian proteins; related reagents |
US8163892B2 (en) | 2002-07-08 | 2012-04-24 | Oncolys Biopharma, Inc. | Oncolytic virus replicating selectively in tumor cells |
WO2005019258A2 (fr) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions et methodes de traitement de maladies relatives au systeme immunitaire |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045712A2 (fr) * | 1997-04-08 | 1998-10-15 | Human Genome Sciences, Inc. | 20 proteines humaines secretees |
WO1998048274A1 (fr) * | 1997-04-22 | 1998-10-29 | Smithkline Beecham Corporation | Test par fluorescence homogene pour mesurer l'effet des composes sur l'expression d'un gene |
WO1999025825A2 (fr) * | 1997-11-13 | 1999-05-27 | Genset | ADNc ETENDUS POUR PROTEINES SECRETEES |
WO2001055301A2 (fr) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
WO2001090325A2 (fr) * | 2000-05-19 | 2001-11-29 | Millennium Pharmaceuticals, Inc. | 50365, un nouveau membre de la famille hexokinase et utilisations |
WO2002008399A2 (fr) * | 2000-07-21 | 2002-01-31 | Incyte Genomics, Inc. | Kinases humaines |
-
2001
- 2001-08-29 WO PCT/US2001/027127 patent/WO2002020754A2/fr not_active Application Discontinuation
- 2001-08-29 CA CA002421265A patent/CA2421265A1/fr not_active Abandoned
- 2001-08-29 EP EP01966454A patent/EP1364015A2/fr not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045712A2 (fr) * | 1997-04-08 | 1998-10-15 | Human Genome Sciences, Inc. | 20 proteines humaines secretees |
WO1998048274A1 (fr) * | 1997-04-22 | 1998-10-29 | Smithkline Beecham Corporation | Test par fluorescence homogene pour mesurer l'effet des composes sur l'expression d'un gene |
WO1999025825A2 (fr) * | 1997-11-13 | 1999-05-27 | Genset | ADNc ETENDUS POUR PROTEINES SECRETEES |
WO2001055301A2 (fr) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
WO2001090325A2 (fr) * | 2000-05-19 | 2001-11-29 | Millennium Pharmaceuticals, Inc. | 50365, un nouveau membre de la famille hexokinase et utilisations |
WO2002008399A2 (fr) * | 2000-07-21 | 2002-01-31 | Incyte Genomics, Inc. | Kinases humaines |
Non-Patent Citations (2)
Title |
---|
DATABASE EMBL [online] EBI Hinxton, UK; 30 November 1999 (1999-11-30), NCI.CGAP: "National Cancer Institute, Cancer Genome Anatomy Project (CGAP)", XP002218725, Database accession no. AW194769 * |
NISHI S ET AL: "HUMAN HEXOKINASE SEQUENCES OF AMINO AND CARBOXYL-TERMINAL HALVES ARE HOMOLOGOUS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 157, no. 3, 1988, pages 937 - 943, XP002218724, ISSN: 0006-291X * |
Also Published As
Publication number | Publication date |
---|---|
EP1364015A2 (fr) | 2003-11-26 |
CA2421265A1 (fr) | 2002-03-14 |
WO2002020754A2 (fr) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002097031A3 (fr) | Molecules utilisees a des fins diagnostiques et therapeutiques | |
WO2004023973A3 (fr) | Molecules utilisees a des fins diagnostiques et therapeutiques | |
WO2000073509A3 (fr) | Molecules utilisees a des fins diagnostiques et therapeutiques | |
PL399351A1 (pl) | Czasteczka przeciwciala, zwiazek ja zawierajacy, sekwencja DNA, wektor do klonowania lub ekspresji, komórka gospodarza, sposób wytwarzania czasteczki przeciwciala, kompozycja terapeutyczna lub diagnostyczna, zastosowanie czasteczki lub zwiazku | |
WO2002083876A3 (fr) | Molecules secretoires | |
WO1998050554A3 (fr) | POLYNUCLEOTIDES ET POLYPEPTIDES D'$i(ENTEROCOCCUS FAECALIS) | |
WO2005056600A3 (fr) | Anticorps monoclonaux se liant ou neutralisant le virus de la dengue | |
HUP0401591A2 (hu) | Új receptor-nukleinsavak és- polipeptidek | |
WO2001004264A3 (fr) | Genes associes a l'atherosclerose | |
WO2002046228A3 (fr) | Recepteur de la toxine du b. anthracis | |
WO2001068859A3 (fr) | Molecules du type recepteur de l'interleukine 17 et leur utilisation | |
WO2001068705A3 (fr) | Molecules du type recepteur de l'interleukine 17 et leurs utilisations | |
WO2003062376A3 (fr) | Molécules pour le diagnostic et la thérapeutique | |
WO2002040715A3 (fr) | Molecules permettant la detection et le traitement de maladies | |
WO2002059315A3 (fr) | Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation | |
WO2002012338A3 (fr) | Procede de criblage | |
WO2002020756A3 (fr) | Molécules sécrétoires | |
WO2001062927A3 (fr) | Molecules utilisees a des fins diagnostiques et therapeutiques | |
WO2001062922A3 (fr) | Molecules destinees a la detection et au traitement de maladies | |
WO2002020754A3 (fr) | Molecules utilisees a des fins diagnostiques et therapeutiques | |
WO2003062385A3 (fr) | Molecules secretoires | |
WO2001062918A3 (fr) | Molecules secretoires | |
WO2002055738A3 (fr) | Molecules pour la detection et le traitement de maladies | |
WO2002079473A3 (fr) | Molecules utilisees a des fins diagnostiques et therapeutiques | |
WO2001021836A3 (fr) | Molecules pour le diagnostic et la therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2421265 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001966454 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001966454 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001966454 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |